Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Piramal Pharma Revenue Increases 12% YoY in Q1 | ||
Fr | Cellectis' UCART22 Granted ODD and RPDD Status by FDA | ||
Do | Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN | ||
Do | Emmes, Miimansa AI Partner on Generative AI in Clinical Research | ||
Do | Stuart Therapeutics Taps Dr. Lukas Scheibler as Chief Science & Technology Officer | ||
Do | Almac Completes FDA Inspection at Charnwood, UK Facilities | ||
Do | Capra Biosciences Receives $7.5M Project Agreement | ||
Do | Catalyst Grants Kye Exclusive Canadian Commercial Rights to AGAMREE | ||
Do | Xavo Welcomes Plexium as Its Latest Client | ||
Do | Neuraxpharm to Utilize Veeva Quality Applications | ||
Mi | RxSource to Relocate to Larger Facility in West Deptford, NJ | ||
Mi | Carbogen Amcis Completes FDA Inspections at Two Manufacturing Sites | ||
Mi | Johnson & Johnson Strengthens Position in Italy with €580M Investment | ||
Mi | Agilent to Acquire North American CDMO BioVectra | ||
Mi | De Motu Cordis Expands DPI Partnership with Catalent | ||
Mi | IDT Bolsters CRISPR Portfolio with SeQure Dx Licensing Deal | ||
Mi | Scorpius Holdings Set to Launch First cGMP Mammalian Manufacturing Campaign | ||
Mi | Beacon Therapeutics Appoints New CEO and CFO | ||
Di | ViroCell Signs Master Services Agreement with Prominent Cancer Center | ||
Di | MidEuropa Agrees to Acquire Famar | ||
Di | Pace Life Sciences Names Head of Commercial | ||
Di | Galderma Granted Manufacturing License Updates for New Biologics Capabilities | ||
Di | Nordic Bioproducts Receives EXCiPACT Certification for MCC Production at Lappeenranta Facility | ||
Di | Navin Molecular Expands GMP Manufacturing Capabilities | ||
Di | Emmaus Life Sciences Appoints Willis C. Lee as CEO |